Keeping ahead of infectious diseases in Asia-Pacific with increased testing


This briefing paper looks at the testing trends in Asia-Pacific (APAC) using the latest data and insights from the Infectious Diseases Testing Monitor. 

The global impact created when infectious diseases emerge or persist in populations has necessitated an increase in turning to in vitro diagnostics (IVD). As an indispensable tool to manage outbreaks via comprehensive testing strategies across APAC, it has allowed countries to broaden their diagnostics reach and tackle elimination and control goals.

Download the briefing paper to find out:

  • APAC’s infectious disease burden and where countries are focusing their attention most
  • How adoption trends for testing technologies such as immunoassays, molecular diagnostics (MDx), point-of-care (POC) and sequencing differ across APAC
  • How the usage of different SARS-CoV-2 tests across APAC varies according to each country’s covid-19 strategy and local testing capacity
  • APAC domestic players to watch in the infectious disease diagnostics market.

Navigating the future of infectious disease testing in APAC

Economist Intelligence Clearstate expects strong growth for APAC’s infectious disease IVD market as the infectious disease burden increases. IVD companies will need to understand how they can meet rising demand for testing in the region. 

Through our team of consultants and the Infectious Diseases Testing Monitor (IDTM)–our proprietary data solution, we support your strategic and tactical business planning, and provide answers on how to best gain market share. 

Download the free report

Fill in the form below to access the report

Infectious Disease Testing Monitor: Clearstate's latest proprietary market tracker